Charlotte Oberröhrmann

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Staphylococcus Aureus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kirsten Schmidt-Hellerau, Nina Baade, Marina Günther, Nadine Scholten, Christoph Heinrich Lindemann, Charlotte Leisse, Charlotte Oberröhrmann, Sophie Peter, Norma Jung, Isabelle Suarez, Carola Horn, Peter Ihle, Jutta Küpper-Nybelen, Anna Hagemeier, Martin Gunnar Hellmich, Clara Lehmann
Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. Infection 52 (4) (2024)
Kirsten Schmidt-Hellerau, Nina Baade, Marina Günther, Nadine Scholten, Christoph Heinrich Lindemann, Charlotte Leisse, Charlotte Oberröhrmann, Sophie Peter, Norma Jung, Isabelle Suarez, Carola Horn, Peter Ihle, Jutta Küpper-Nybelen, Anna Hagemeier, Martin Gunnar Hellmich, Clara Lehmann
Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. Infection (2024)
Kirsten Schmidt-Hellerau, Nina Baade, Marina Günther, Nadine Scholten, Christoph Heinrich Lindemann, Charlotte Leisse, Charlotte Oberröhrmann, Sophie Peter, Norma Jung, Isabelle Suarez, Carola Horn, Peter Ihle, Jutta Küpper-Nybelen, Anna Hagemeier, Martin Gunnar Hellmich, Clara Lehmann
Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. Infection 52 (4) (2024)
Kirsten Schmidt-Hellerau, Nina Baade, Marina Günther, Nadine Scholten, Christoph Heinrich Lindemann, Charlotte Leisse, Charlotte Oberröhrmann, Sophie Peter, Norma Jung, Isabelle Suarez, Carola Horn, Peter Ihle, Jutta Küpper-Nybelen, Anna Hagemeier, Martin Gunnar Hellmich, Clara Lehmann
Outpatient parenteral antimicrobial therapy (OPAT) in Germany: insights and clinical outcomes from the K-APAT cohort study. Infection 52 (4) (2024)